Business
Boston Scientific's Surging Heart Device Demand and Margin Resilience Redefine Growth Trajectory
Boston Scientific's latest earnings beat and raised guidance, fueled by strong demand for its electrophysiology devices, signal a strategic shift. The company is navigating tariff pressures while expanding margins, with major acquisitions poised to reshape its long-term profile.